Statins reduce risk of blood clots
Prescribing a statin significantly reduces the risk of venous thromboembolism, an international study concludes.
A trial of 17,800 patients given either rosuvastatin 20mg or placebo daily found that after a median follow-up of 1.9 years rates of VTE were 0.18 and 0.32 per 100 person-years respectively.
The risk of VTE was reduced by 43%, and risk of pulmonary embolism by 23%, in the rosuvastatin group compared with placebo.
N Engl J Med 2009; 29 March early online publication